PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-69

  1. mac9
    842 Posts.
    lightbulb Created with Sketch. 761
    clock Created with Sketch.
    24/04/21
    18:33
    Post #: 52700570
    I believe we are already receiving expedited pathways providing regulatory streamlining mechanisms due to ODD and RPDD.
    I am not aware at this time that we have applied for Fast Track.
    ANP Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
FBU Fletcher Building sells Tradelink for $170M, says plumbing division "not a natural fit"
right-arrow Created with Sketch.
CAR Driving up revenue - & the share price today
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Finding financial stability when inflation's out of control
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.7¢ $41.16K 516.9K

Buyers (Bids)

No. Vol. Price($)
1 74175 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 1272 1
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.